JPI InvestFrançais
JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool's data · not financial advice · full analysis (free)
All stocksHealth CareRGEN › Financials

Repligen (RGEN): financial analysis & fundamentals

Health Care · price $182 · market cap $10.3 B
In short — Repligen trades at 252.8× earnings (P/E), 69.0× expected earnings, for a PEG of — and a net margin of 5%. Revenue growth 12%. Quick verdict: valuation to review.

📈 See the interactive version (live chart) →

🔗 Related pages on Repligen — Are analysts right?  ·  If I had invested

Valuation & profitability

MetricValueWhat it means
P/E (price / earnings)252.8The higher, the more growth the market expects.
Forward P/E69.0On next year's expected earnings. Lower than current P/E = rising earnings.
PEG (P/E ÷ growth)Below 1 = cheap given growth; above 2 = expensive.
Net margin5%Share of revenue that ends up as profit.
Revenue growth12%Pace of revenue growth.
Price-to-book4.9Price relative to book value.
Market cap$10.3 BTotal market value of the company.
Dividend yieldNo dividend currently.

Income statement (by year)

YearRevenueNet incomeNet margin
2022$802 M$186 M23%
2023$639 M$42 M7%
2024$634 M$-26 M-4%
2025$738 M$49 M7%

📊 Open the interactive Repligen page (charts, live news) →

Frequently asked questions

Is Repligen stock expensive?

Repligen has a P/E of 252.8 (forward P/E 69.0) and a PEG of —. A PEG below 1 is rather cheap given growth, above 2 is expensive. Verdict: valuation to review.

What is Repligen's net margin?

Repligen's net margin is about 5% — the share of revenue that ends up as net profit.

What is Repligen's revenue?

Latest known revenue: $738 M for net income of $49 M. The year-by-year breakdown is in the income statement above.

What is Repligen's market cap?

Repligen (RGEN) has a market cap of about $10.3 B.

Does Repligen pay a dividend?

No, Repligen does not currently pay a dividend (it reinvests earnings).

What is JPI Invest?

JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best — on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.

Explore JPI Invest for free → How it works: the method →

⚠️ Educational information, not investment advice. Data: Yahoo Finance, recomputed by JPI Invest. A stock can be « cheap » for a bad reason.